These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 32126319)

  • 1. Statins reduce vascular inflammation in atherogenesis: A review of underlying molecular mechanisms.
    Liberale L; Carbone F; Montecucco F; Sahebkar A
    Int J Biochem Cell Biol; 2020 May; 122():105735. PubMed ID: 32126319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-inflammatory effects of statins: clinical evidence and basic mechanisms.
    Jain MK; Ridker PM
    Nat Rev Drug Discov; 2005 Dec; 4(12):977-87. PubMed ID: 16341063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial dysfunction, oxidative stress and inflammation in atherosclerosis: beneficial effects of statins.
    Lahera V; Goicoechea M; de Vinuesa SG; Miana M; de las Heras N; Cachofeiro V; Luño J
    Curr Med Chem; 2007; 14(2):243-8. PubMed ID: 17266583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on statin-mediated anti-inflammatory activities in atherosclerosis.
    Montecucco F; Mach F
    Semin Immunopathol; 2009 Jun; 31(1):127-42. PubMed ID: 19415282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atherosclerosis: anti-inflammatory and immunomodulatory activities of statins.
    Kwak BR; Mulhaupt F; Mach F
    Autoimmun Rev; 2003 Oct; 2(6):332-8. PubMed ID: 14550874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiinflammatory and immunomodulatory properties of statins.
    Shovman O; Levy Y; Gilburd B; Shoenfeld Y
    Immunol Res; 2002; 25(3):271-85. PubMed ID: 12018465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HMG-CoA reductase inhibitors: effects on chronic subacute inflammation and onset of atherosclerosis induced by dietary cholesterol.
    Kleemann R; Kooistra T
    Curr Drug Targets Cardiovasc Haematol Disord; 2005 Dec; 5(6):441-53. PubMed ID: 16503864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pleiotropic effects of statins: stabilization of the vulnerable atherosclerotic plaque?
    Akdim F; van Leuven SI; Kastelein JJ; Stroes ES
    Curr Pharm Des; 2007; 13(10):1003-12. PubMed ID: 17430164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. To cardiovascular disease and beyond: new therapeutic perspectives of statins in autoimmune diseases and cancer.
    Lopez-Pedrera C; Ruiz-Limon P; Valverde-Estepa A; Barbarroja N; Rodriguez-Ariza A
    Curr Drug Targets; 2012 Jun; 13(6):829-41. PubMed ID: 22250652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statins and the endothelium.
    Ii M; Losordo DW
    Vascul Pharmacol; 2007 Jan; 46(1):1-9. PubMed ID: 16920035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as antiinflammatory agents?
    Schönbeck U; Libby P
    Circulation; 2004 Jun; 109(21 Suppl 1):II18-26. PubMed ID: 15173059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials.
    Antonopoulos AS; Margaritis M; Lee R; Channon K; Antoniades C
    Curr Pharm Des; 2012; 18(11):1519-30. PubMed ID: 22364136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innate and adaptive inflammation as a therapeutic target in vascular disease: the emerging role of statins.
    Tousoulis D; Psarros C; Demosthenous M; Patel R; Antoniades C; Stefanadis C
    J Am Coll Cardiol; 2014 Jun; 63(23):2491-2502. PubMed ID: 24613322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statins: pros and cons.
    Pinal-Fernandez I; Casal-Dominguez M; Mammen AL
    Med Clin (Barc); 2018 May; 150(10):398-402. PubMed ID: 29292104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward immunomodulatory and anti-inflammatory properties of statins.
    Arnaud C; Braunersreuther V; Mach F
    Trends Cardiovasc Med; 2005 Aug; 15(6):202-6. PubMed ID: 16182129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins and atherosclerosis: the role of epigenetics.
    Storino Farina M; Rojano Rada J; Molina Garrido A; Martínez X; Pulgar A; Paniagua R; Garrido J
    Medwave; 2015 Nov; 15(10):e6324. PubMed ID: 26639162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rho kinase: an important mediator of atherosclerosis and vascular disease.
    Zhou Q; Liao JK
    Curr Pharm Des; 2009; 15(27):3108-15. PubMed ID: 19754385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins and autoimmune diseases.
    Riboldi P; Gerosa M; Meroni PL
    Lupus; 2005; 14(9):765-8. PubMed ID: 16218484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesterol-independent effects of statins in inflammation, immunomodulation and atherosclerosis.
    Arnaud C; Veillard NR; Mach F
    Curr Drug Targets Cardiovasc Haematol Disord; 2005 Apr; 5(2):127-34. PubMed ID: 15853754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation and beyond: new directions and emerging drugs for treating atherosclerosis.
    Bertrand MJ; Tardif JC
    Expert Opin Emerg Drugs; 2017 Mar; 22(1):1-26. PubMed ID: 27927063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.